MXCT

MaxCyte 2025 Financial Results Review

MaxCyte 2025 Financial Results Review

MaxCyte, Inc. (MXCT) posted a Q4 2025 GAAP loss of $0.09 per share, wider than the -$0.08 expected loss (10.3%…

MaxCyte Inc (MXCT) Q3 2022 Earnings Call

MaxCyte Inc (NASDAQ: MXCT) Q3 2022 Earnings Conference

MaxCyte Inc (MXCT) Q2 2022 earnings call

MaxCyte Inc (NASDAQ: MXCT) Q2 2022 Earnings Conference

MaxCyte Inc (MXCT) Q1 2022

MaxCyte Inc (NASDAQ: MXCT) Q1 2022 Earnings Conference

MaxCyte Inc (MXCT) Q4 2021 Earnings Conference Call

MaxCyte Inc (NASDAQ: MXCT) Q4 2021 Earnings Conference

MaxCyte Inc (MXCT) MaxCyte to Report Third Quarter 2021 Financial Results on November 10, 2021

MaxCyte Inc (NASDAQ: MXCT) Q3 2021 Earnings Conference

MaxCyte Inc (MXCT) MaxCyte to Report Second Quarter 2021 Financial Results on September 13, 2021

MaxCyte Inc (NASDAQ: MXCT) Q2 2021 Earnings Conference